Daewoong Stock Forecast for 2023 - 2025 - 2030
Updated on 04/26/2024
Daewoong Stock Forecast and Price Target
The average target price for Daewoong's stock set by renowned analysts in recent months is ₩25000.00, representing a potential upside of approximately 39.66% from its last closing price if met by 2025. This estimation is based on a high estimate of ₩25000.00 and a low estimate of ₩25000.00. If you are interested in A003090 stock, it is important to also consider its competitors.
39.66% Upside
Daewoong Fair Value Forecast for 2023 - 2025 - 2030
In the last year, Daewoong's Price has decreased from ₩30.35k to ₩0.00 – a 100.00% drop. In the next year, analysts believe that Fair Value will reach ₩0.00 – an increase of 100.00%. For the next six years, the forecast is forFair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A128940 Stock Forecast | Hanmi Pharm. | Outperform |
18
|
₩310.00k | Buy/Sell | ₩382.71k | 33.87% |
| A008930 Stock Forecast | Hanmi Science | - |
14
|
₩42.55k | Buy/Sell | ₩0.00 | -100.00% |
| A000250 Stock Forecast | Sam Chun Dang Pharm. | - |
6
|
₩104.70k | Buy/Sell | ₩80.00k | -100.00% |
| A145020 Stock Forecast | Hugel | Buy |
16
|
₩206.50k | Buy/Sell | ₩201.75k | 6.05% |
| A009420 Stock Forecast | Hanall Biopharma | Buy |
14
|
₩34.45k | Buy/Sell | ₩44.67k | 30.62% |
Daewoong Revenue Forecast for 2023 - 2025 - 2030
Daewoong's Revenue has seen growth In the last two years, going from ₩1.36T to ₩1.70T – a gain of 25.23% In the following year, 0 experts forecast that Daewoong's Revenue will decrease by 10.75%, to ₩1.51T. In 2030, professionals predict that Daewoong's Revenue will decrease by 10.13%, to ₩1.53T.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A019170 Stock Forecast | Shinpoong Pharmaceutical Co.,L... | - |
14
|
₩12.96k | Buy/Sell | ₩0.00 | -100.00% |
| A069620 Stock Forecast | Daewoong pharmaceutical Co.,Lt... | Buy |
16
|
₩110.50k | Buy/Sell | ₩156.10k | 40.27% |
| A185750 Stock Forecast | Chong Kun Dang Pharmaceutical | Outperform |
16
|
₩100.60k | Buy/Sell | ₩124.29k | 49.11% |
.jpg)
Daewoong Dividend per Share Forecast for 2023 - 2025 - 2030
In the last year, Daewoong's Dividend per Share has decreased by 0.00%, going from ₩100.00 to ₩100.00. 0 analysts predict Daewoong's Dividend per Share will decrease by 0.00% in the next year, reaching ₩100.00. By 2030, professionals predict that Daewoong's Dividend per Share will decrease by 0.00%, to ₩100.00.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A005250 Stock Forecast | Green Cross Holdings | - |
16
|
₩16.17k | Buy/Sell | ₩0.00 | -100.00% |
| A001060 Stock Forecast | JW Pharmaceutical | Buy |
14
|
₩29.80k | Buy/Sell | ₩40.62k | 40.94% |
| A003850 Stock Forecast | Boryung | Buy |
17
|
₩10.95k | Buy/Sell | ₩13.50k | 46.12% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A086450 Stock Forecast | DongKook Pharmaceutical | Buy |
16
|
₩15.94k | Buy/Sell | ₩20.00k | 50.56% |
| A000640 Stock Forecast | Dong-A Socio Holdings | - |
13
|
₩110.20k | Buy/Sell | ₩0.00 | -100.00% |
| A170900 Stock Forecast | Dong-A ST | Outperform |
17
|
₩69.00k | Buy/Sell | ₩74.50k | 18.12% |
Daewoong EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Daewoong's EBITDA has increased by 71.66%, going from ₩148.90B to ₩255.61B. In the following year, the 0 analysts surveyed believe that Daewoong's EBITDA will decrease by 17.89%, reaching ₩209.88B. According to professionals, by 2030, Daewoong's EBITDA will have decreased by 16.09%, falling down to ₩214.48B.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A058820 Stock Forecast | CMG Pharmaceutical | - |
14
|
₩2.24k | Buy/Sell | ₩0.00 | -100.00% |
| A140410 Stock Forecast | Mezzion Pharma | - |
6
|
₩36.55k | Buy/Sell | ₩0.00 | -100.00% |
| A102460 Stock Forecast | REYON Pharmaceutical | - |
15
|
₩15.75k | Buy/Sell | ₩0.00 | -100.00% |
Daewoong EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Daewoong's EBIT has grown, increasing from ₩98.06B to ₩207.33B – an increase of 111.45%. The next year, 0 experts forecast that Daewoong's EBIT will decrease by 23.38%, reaching ₩158.85B. In 2030, professionals predict that Daewoong's EBIT will decrease by 20.32%, reaching ₩165.20B.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A047920 Stock Forecast | HLB Pharmaceutical | - |
4
|
₩34.65k | Buy/Sell | ₩0.00 | -100.00% |
| A007570 Stock Forecast | Ilyang Pharmaceutical Co.,Ltd | - |
13
|
₩14.56k | Buy/Sell | ₩0.00 | -100.00% |
| A003000 Stock Forecast | Bukwang Pharmaceutical | - |
10
|
₩6.15k | Buy/Sell | ₩17.66k | -100.00% |
Daewoong EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last year, Daewoong's EPS has decreased from ₩2981.00 to ₩0.00 – a 100.00% drop. In the next year, analysts believe that EPS will reach ₩0.00 – an increase of 100.00%. For the next six years, the forecast is forEPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A053030 Stock Forecast | BINEX | - |
16
|
₩13.59k | Buy/Sell | ₩18.00k | -59.42% |
| A249420 Stock Forecast | Ildong Pharmaceutical | Outperform |
12
|
₩15.07k | Buy/Sell | ₩23.00k | 52.62% |
| A243070 Stock Forecast | Huons | Outperform |
18
|
₩34.25k | Buy/Sell | ₩45.00k | 57.66% |
.jpg)